The expanding world of co-stimulation: the two-signal model revisited
Trends in Immunology, ISSN: 1471-4906, Vol: 22, Issue: 4, Page: 217-223
2001
- 180Citations
- 67Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations180
- Citation Indexes180
- 180
- CrossRef144
- Captures67
- Readers67
- 67
Review Description
The crucial role for CD28, its homolog CTLA-4 and their binding partners B7-1 and B7-2 in the generation of effective T-cell responses has been well documented. Recently, two new pairs of the CD28/B7 families were identified. The ability of these molecules to regulate T-cell expansion and effector function and the dynamic integration of the co-stimulatory and T-cell receptor signals are just beginning to be explored. Understanding these processes will be crucial for designing clinically relevant approaches to manipulate the adaptive immune system.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1471490601018683; http://dx.doi.org/10.1016/s1471-4906(01)01868-3; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0034921235&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/11274928; http://linkinghub.elsevier.com/retrieve/pii/S1471490601018683; http://api.elsevier.com/content/article/PII:S1471490601018683?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1471490601018683?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1471490601018683
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know